Therapeutic treatments for blood cell deficiencies

Details for Australian Patent Application No. 2005237117 (hide)

Owner Hollis-Eden Pharmaceuticals, Inc.

Inventors Reading, Christopher L; Prendergast, Patrick T; Frincke, James Martin

Agent Griffith Hack

Pub. Number AU-B-2005237117

Parent 782736

Filing date 23 November 2005

Wipo publication date 15 December 2005

Acceptance publication date 4 September 2008

International Classifications

A61K 31/00 (2006.01)

A61K 31/122 (2006.01) - having the oxygen atom directly attached to a ring, e.g. quinones, vitamin K, anthralin

A61K 31/17 (2006.01) - having the group NC(O)N or NC(S)N, e.g. urea, thiourea, carmustine

A61K 31/19 (2006.01)

A61K 31/198 (2006.01)

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61K 31/429 (2006.01) - condensed with heterocyclic ring systems

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

A61K 31/565 (2006.01) - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

A61K 31/568 (2006.01) - substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstane, testosterone

A61K 31/739 (2006.01) - Lipopolysaccharides

A61K 33/00 (2006.01) Medicinal preparations containing inorganic active ingredients

A61K 33/14 (2006.01) Medicinal preparations containing inorganic active ingredients - Alkali metal chlorides

A61K 35/74 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

C07J 1/00 (2006.01) Normal steroids, i.e. cyclopenta[a]hydrophenanthrenes, containing carbon, hydrogen, halogen, or oxygen

C07J 17/00 (2006.01) Normal steroids containing carbon, hydrogen, halogen, or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta[a]hydrophenanthrene skeleton

C07J 73/00 (2006.01) Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms

Event Publications

8 December 2005 Complete Application Filed

15 December 2005 Application Open to Public Inspection

  Published as AU-B-2005237117

29 June 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

4 September 2008 Application Accepted

  Published as AU-B-2005237117

8 January 2009 Standard Patent Sealed

10 June 2010 Alteration of Name

  The name of the patentee has been altered to Harbor Biosciences, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005237118-Ring slicer with easily removable knife and knife assembly

2005237116-Apparatus and method for improving recognition performance for dark region of image